HYPERION DEFI, INC. Loss Contingency, Estimate of Possible Loss
HYPERION DEFI, INC. (HYPD) had Loss Contingency, Estimate of Possible Loss of $489.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LossContingencyEstimateOfPossibleLoss · last filed 2026-03-30
- 2025-12-31: Loss Contingency, Estimate of Possible Loss $489.00K.
- 2024-12-31: Loss Contingency, Estimate of Possible Loss $1.03M.
| Period end | Loss Contingency, Estimate of Possible Loss |
|---|---|
| 2025-12-31 | $489.00K 10-K · filed 2026-03-30 |
| 2024-12-31 | $1.03M 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |